May 4, 2011
1:11-cv-00395
35:145 Patent Infringement
News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Impax Laboratories Inc. on Friday inked a deal with two Johnson & Johnson subsidiaries, giving Impax licensing rights to produce generic versions of the attention deficit hyperactivity disorder drug Concerta and putting to rest a lengthy patent infringement battle against the generic drugmaker.